[1]. Alexander, M. (2000). Aging, bioavailability, and overestimation of risk from environmental pollutants. Environmental Science & Technology, 34(20), pp.4259-4265.
[2]. Perera, F., Herbstman, J. (2011). Prenatal environmental exposures, epigenetics, and disease. Reproductive Toxicology, 31(3): 363-373.
[3]. Kota, S. K., Feil, R. (2010). Epigenetic transitions in germ cell development and meiosis. Dev. Cell, 19, 675–686.
[4]. Feil, R., Fraga, M. F. (2012). Epigenetics and the environment: emerging patterns and implications. Nature Reviews Genetics, 13(2): 97.
[5]. Hou, L., Zhang, X., Wang, D. and Baccarelli, A. (2011). Environmental chemical exposures and human epigenetics. International Journal of Epidemiology, 41(1), pp.79-105
[6]. Dawson, M. A., Kouzarides, T. (2012). Cancer epigenetics: from mechanism to therapy. Cell, 150(1): 12-27.
[7]. Gavrilescu, M., et al. (2015). Emerging pollutants in the environment: present and future challenges in biomonitoring, ecological risks and bioremediation. New Biotechnology, 32(1): 147-156.
[8]. Yamamura, S., Amachi, S. (2014). Microbiology of inorganic arsenic: from metabolism to bioremediation. Journal of Bioscience and Bioengineering, 118(1): 1-9.
[9]. Megharaj, M., et al. (2011). Bioremediation approaches for organic pollutants: a critical perspective. Environment International, 37(8): 1362-1375.
[10]. Wilson, S. C., Jones, K. C. (1993). Bioremediation of soil contaminated with polynuclear aromatic hydrocarbons (PAHs): a review. Environmental Pollution, 81(3): 229-249